BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 26452314)

  • 1. Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate With Lymph Node Metastasis and Molecular Subtypes.
    Shrivastav S; Bal A; Singh G; Joshi K
    Clin Breast Cancer; 2016 Apr; 16(2):131-8. PubMed ID: 26452314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis markers in breast cancer--potentially useful tools for priority setting of anti-angiogenic agents.
    Keyhani E; Muhammadnejad A; Behjati F; Sirati F; Khodadadi F; Karimlou M; Moghaddam FA; Pazhoomand R
    Asian Pac J Cancer Prev; 2013; 14(12):7651-6. PubMed ID: 24460348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Bax and Bcl-2 in tumour cells and blood vessels of breast cancer and their association with angiogenesis and hormonal receptors.
    Jaafar H; Abdullah S; Murtey MD; Idris FM
    Asian Pac J Cancer Prev; 2012; 13(8):3857-62. PubMed ID: 23098483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer.
    Park MH; Kwon HJ; Kim JR; Lee B; Lee SJ; Bae YK
    Ann Surg Oncol; 2017 Nov; 24(12):3780-3787. PubMed ID: 28634667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
    Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B
    J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 expression does not correlate with microvessel density in breast cancer.
    Thorat MA; Mehrotra S; Morimiya A; Badve S
    Pathobiology; 2009; 76(1):39-44. PubMed ID: 19188749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of invasive breast ductal carcinoma, NOS, diagnosed in a tertiary institution in the East Coast of Malaysia with a focus on tumor angiogenesis.
    Ch'ng ES; Tuan Sharif SE; Jaafar H
    Asian Pac J Cancer Prev; 2012; 13(9):4445-52. PubMed ID: 23167359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
    Jang KS; Han HX; Paik SS; Brown PH; Kong G
    Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 is a prognostic marker for hormone receptor positive tumors.
    Pérez-López ME; García-Gómez J; Alves MT; Paradela A; García-Mata J; García-Caballero T
    Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of progression and invasion in short term follow up of untreated breast cancer patients.
    Rabi ZA; Todorović-Raković N; Vujasinović T; Milovanović J; Nikolić-Vukosavljević D
    Cancer Biomark; 2015; 15(6):745-54. PubMed ID: 26406416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India.
    Ambroise M; Ghosh M; Mallikarjuna VS; Kurian A
    Asian Pac J Cancer Prev; 2011; 12(3):625-9. PubMed ID: 21627355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.
    Yagi T; Inoue N; Yanai A; Murase K; Imamura M; Miyagawa Y; Enomoto Y; Nishimukai A; Takatsuka Y; Hirota S; Akazawa K; Miyoshi Y
    Breast Cancer; 2016 Mar; 23(2):224-30. PubMed ID: 25082658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients.
    Yonenaga Y; Mori A; Onodera H; Yasuda S; Oe H; Fujimoto A; Tachibana T; Imamura M
    Oncology; 2005; 69(2):159-66. PubMed ID: 16127287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.
    Han Z; Chen Z; Zheng R; Cheng Z; Gong X; Wang D
    World J Surg Oncol; 2015 Feb; 13():56. PubMed ID: 25889325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Tumor-Infiltrating Lymphocyte Density Assessed Using a Standardized Method Based on Molecular Subtypes and Adjuvant Chemotherapy in Invasive Breast Cancer.
    Jang N; Kwon HJ; Park MH; Kang SH; Bae YK
    Ann Surg Oncol; 2018 Apr; 25(4):937-946. PubMed ID: 29330719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters.
    El-Gendi S; Abdel-Hadi M
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
    Eberhard A; Kahlert S; Goede V; Hemmerlein B; Plate KH; Augustin HG
    Cancer Res; 2000 Mar; 60(5):1388-93. PubMed ID: 10728704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
    Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
    J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.